Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
series B
Pharma
Contraline gins up $92.5M in male birth control development push
Contraline is developing what could be a first-in-class male birth control that has garnered enthusiasm from a host of big-name investors.
Fraiser Kansteiner
Jun 2, 2026 8:00am
Ansa snares $54.4M in series B to boost its DNA synthesis tech
Oct 2, 2025 8:50am
Phlow reaps $36M in series B fundraising to boost CDMO program
Apr 6, 2023 9:35am
SaNOtize bags $24M to fund phase 3 trial of COVID-19 nasal spray
Aug 30, 2022 9:55am
Ori Biotech reaps $100M in series B round of fundraising
Jan 18, 2022 9:10am
Gene therapy 'development engine' nabs $120M to amp up CDMO work
Apr 29, 2021 8:00am
